From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
March 5, 2025
Philadelphia, PA, March 5, 2025 – IntegriChain, the leading provider of pharma revenue optimization technology and insights, will host the annual RAC Summit, March 27, 2025, in East Brunswick, NJ, sponsored by the Revenue Analytics Collaborative (RAC). The RAC Summit is free to Pharmaceutical manufacturers who wish to learn more about industry challenges and regulations related to pricing and reimbursement, ask questions about commercialization and net revenue optimization, and share best practices amongst industry colleagues. Jeff Baab, an IntegriChain Partner in the Consulting and Advisory practice, will keynote the event and explore significant policy, pricing, and reimbursement pressures that Pharmaceutical professionals face. The event also includes a fireside chat with a voice of the industry featuring Kristen Landon, CCO of 60 Degrees Pharmaceuticals who shares expertise from a 25+-year career; insightful roundtable discussions; and industry networking opportunities.
“The RAC Summit is a can’t-miss event for any Pharma/Biotech business or finance professional in Market Access, Contracts & Pricing, or Finance and Accounting focused on Government, Commercial, and Gross-to-Net strategy, management, and optimization,” said Jen Sharpe, RAC facilitator and Vice President in IntegriChain’s Consulting and Advisory practice. “The collective power of an industry-peer group like the RAC is unmatched, and this event brings together the best of the best to share with those of like experience as well as those newer to the industry. The positive spirit of the event is simply unparalleled, and the insights delivered are tremendously valuable to all participants.”
The RAC Summit’s Roundtable Discussions will include the following pressing topics.
About the Revenue Analytics CollaborativeThe RAC is a private, industry peer networking and benchmarking group with more than 850 industry colleagues from more than 275 manufacturers, sponsored by IntegriChain. Members include business and financial professionals who own, support, and analyze Commercial, Government, Gross-to-Net (GTN), and Trade/Channel data, processes, and systems in Pharmaceutical companies large and small. The RAC offers members benchmarking, workshops, webinars, and lunch-and-learns, confidential advice and guidance, discussion boards, and industry networking. Interested professionals can learn more here: RACollab.org.
About IntegriChainIntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company’s unique combination of data management, enterprise applications, consulting, and outsourcing helps manufacturers achieve better financial results by connecting commercial execution to net revenue. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain’s umbrella of companies include Blue Fin Group and Federal Compliance Solutions, and the company is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India. For more information, visit www.integrichain.com or follow on LinkedIn.
ContactJennifer Guinan | Sage Strategic Marketing | jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
